Sero-conversion of HCV negative patients: a European study on the epidemiology and management of HCV haemodialysis patients.
This paper reports part of the findings from a larger study reported earlier, the European study on epidemiology and the management of HCV in the haemodialysis population (1). Centres recruited to the larger study were monitored for a further one year observation period to measure and generate a deeper understanding of HCV sero-conversion. From 4724 patients who were studied at the baseline, in 68 centres, only 13 patients were found to have sero-converted. These sero-conversions occurred in 7 hospitals within 5 different countries. Possible routes of transmission and risk factors are described with respect to the individual centres and good practice recommendations based on current evidence presented.
Zampieron
A
A
Padua University Hospital, Italy. zampieron@lycos.com
Jayasekera
H
H
Elseviers
M
M
Lindley
E
E
De Vos
J Y
JY
Harrington
M
M
Ormandy
P
P
D001317:Austria / Q000453:epidemiology; D001530:Belgium / Q000453:epidemiology; D019985:Benchmarking; D003428:Cross Infection / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy* / Q000635:transmission; D004203:Disinfection / Q000458:organization & administration; D019317:Evidence-Based Medicine; D006276:Health Facility Size; D006436:Hemodialysis Units, Hospital / Q000458:organization & administration; D006526:Hepatitis C / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy* / Q000635:transmission; D006801:Humans; D017053:Infection Control / Q000458:organization & administration*; D007557:Israel / Q000453:epidemiology; D007558:Italy / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D016134:Organizational Policy; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D013557:Switzerland / Q000453:epidemiology; D017749:Total Quality Management / Q000458:organization & administration